Efficacy and safety of Fondaparinux for prevention of venous thromboembolism (VTE) after abdominal surgery
- Conditions
- Colorectal cancer patients performed laparoscopic surgery at high risk of VTE
- Registration Number
- JPRN-UMIN000006543
- Lead Sponsor
- Kansai Medical University Hirakata hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Not provided
1.Patient who meet contraindication or precaution in package insert of anticoagulants such as Fondaparinux, UFH, LMWH, and Danaparoid 2.Patient who have experience of lower limb orthopedic surgery, abdominal surgery, cardiovascular surgery within 3 month of enrollment 3.Patient who receive contra indicated concomitant drug within 1 week after Fondaparinux administration. 4.VTE patient diagnosed before surgery 5.Patient whose D-dimer above 1 micro gram before surgery 6.Patient who have history of arterial thromboembolism 7.Drug addiction or alcohol abuse. 8.Patient who scheduled other surgery during the study 9.Pregnant women or women who have possibility of pregnancy. 10.Patient who judged inadequate to join the study by the doctor in charge.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method